AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 210 |
Market Cap | 33.55B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 7.53 |
PE Ratio (ttm) | 30.35 |
Forward PE | n/a |
Analyst | Hold |
Ask | 233.99 |
Volume | 481,989 |
Avg. Volume (20D) | 900,745 |
Open | 231.81 |
Previous Close | 230.26 |
Day's Range | 227.68 - 232.07 |
52-Week Range | 168.29 - 260.49 |
Beta | undefined |
About RMD
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use i...
Analyst Forecast
According to 12 analyst ratings, the average rating for RMD stock is "Hold." The 12-month stock price forecast is $250, which is an increase of 9.38% from the latest price.
Next Earnings Release
Analysts project revenue of $1.27B, reflecting a 9.20% YoY growth and earnings per share of 2.31, making a 22.87% increase YoY.